NEJM Editorial Takes Issue With WHO Study On Using Remdesivir To Treat COVID-19
December 03, 2020
Reuters (12/2, Beasley) reports, “An editorial in the influential New England Journal of Medicine cites problems with a World Health Organization (WHO) study that found Gilead Sciences Inc’s antiviral remdesivir failed to improve COVID-19 survival, and sa...